The Trump administration's recent announcement linking acetaminophen, the active ingredient in Tylenol, to an increased risk of autism in children whose mothers used the drug during pregnancy has ignited a firestorm of controversy. This recommendation, which advises limiting acetaminophen use unless medically necessary for fever, directly contradicts the findings of numerous scientific studies that have found no causal relationship between prenatal acetaminophen exposure and autism spectrum disorder (ASD).
The administration's assertion, spearheaded by Health and Human Services Secretary Robert F. Kennedy Jr., is based on a review of previous research, including a meta-analysis suggesting a potential link between prolonged acetaminophen use during pregnancy and neurodevelopmental disorders. However, this review's findings are at odds with more comprehensive studies, such as one analyzing the health records of 2.5 million Swedish children, which found no such connection after controlling for familial factors.
Kenvue, the manufacturer of Tylenol, has strongly refuted the administration's claims, emphasizing the existing scientific consensus on the drug's safety when used as directed. The company highlights the potential risks to both mother and child if women are discouraged from using an effective and approved pain and fever reliever during pregnancy. Untreated fever and pain can lead to serious complications, including miscarriage and birth defects.
Adding to the complexity, the FDA's simultaneous approval of leucovorin, a form of folate, as a treatment for autism has further fueled the debate. While some preliminary studies suggest potential benefits, the long-term efficacy and safety of leucovorin in treating ASD remain unclear. The FDA's initial approval notice was later withdrawn, adding to the uncertainty surrounding this treatment.
The administration's actions have been met with skepticism by the broader scientific community, which overwhelmingly believes that autism is a complex condition caused by a multitude of genetic and environmental factors, and not a single cause. The focus on acetaminophen, alongside the administration's previous actions concerning vaccine policies, has raised concerns about a potential prioritization of unsubstantiated claims over established scientific evidence in the realm of public health.
---
Originally published at: https://www.cnbc.com/2025/09/22/trump-autism-tylenol-acetaminophen-pregnancy.html
